These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. [Factors which influence phosphorus removal in hemodialysis]. Gallar P; Ortiz M; Ortega O; Rodríguez I; Seijas V; Carreño A; Oliet A; Vigil A Nefrologia; 2007; 27(1):46-52. PubMed ID: 17402879 [TBL] [Abstract][Full Text] [Related]
18. Enzyme replacement therapy for Fabry disease: morphologic and histochemical changes in the urinary sediments. Utsumi K; Mitsuhashi F; Asahi K; Sakurazawa M; Arii K; Komaba Y; Katsumata T; Katsura K; Kase R; Katayama Y Clin Chim Acta; 2005 Oct; 360(1-2):103-7. PubMed ID: 16112661 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of Fabry disease among Turkish dialysis patients: Data from hemodialysis centers in Bursa province. Sayilar EI; Ayar Y; Yavuz M Clin Nephrol; 2016 Mar; 85(3):165-72. PubMed ID: 26833297 [TBL] [Abstract][Full Text] [Related]
20. Therapy of Fabry disease. Kleinert J; Hauser AC; Lorenz M; Födinger M; Sunder-Plassmann G Kidney Int; 2004 Sep; 66(3):1288; author reply 1288-9. PubMed ID: 15327431 [No Abstract] [Full Text] [Related] [Next] [New Search]